Non-small Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2021-07-27EMA Withdrawn: Portrazza (necitumumab) — Eli Lilly Nederland B.V.
Portrazza (necitumumab) has been withdrawn by its marketing authorization holder in the EMA framework.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung [Phase 2]
Phase 2 trial updating afatinib in combination with pembrolizumab for non-small cell lung carcinoma (squamous cell) has been completed with …
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma [Phase 1]
Phase 1 trial update evaluating nintedanib with weekly docetaxel in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Afatinib Osimertinib Sequencing NIS
A completed clinical trial evaluating sequencing of afatinib and osimertinib in non-small cell lung carcinoma; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer [Phase 2]
Phase 2 trial of PF-00299804 in patients with advanced refractory non-small cell lung carcinoma completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2020-09-24Clinical Trial Update: LUME BioNIS: a Biomarker Study in Patients With NSCLC
A completed biomarker study in patients with non-small cell lung carcinoma (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Pazopanib in Molecularly Selected Patients With Advanced NSCLC [Phase 2]
Phase 2 trial update of Pazopanib in molecularly selected patients with advanced non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: A Study of DS-2248 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for DS-2248 in advanced solid tumors; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC [Phase 1]
Phase 1 study of Carotuximab (TRC105) in combination with Nivolumab in metastatic non-small cell lung carcinoma has completed with results p…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence [Phase 2]
Phase 2 trial comparing image-guided adaptive conformal photon therapy versus proton therapy with concurrent chemotherapy for locally advanc…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients [Phase 2]
Phase 2 trial update of Tarceva (OSI-774) in previously untreated elderly patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of TAK-659 in combination with nivolumab in advanced solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older [Phase 4]
Phase 4 trial update of afatinib for EGFR mutation-positive non-small cell lung cancer in patients aged 70 or older; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. [Phase 4]
A Phase 4 randomized trial comparing erlotinib versus pemetrexed in maintenance treatment for advanced non-small cell lung cancer; the study…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer [Phase 3]
Phase III trial comparing BI 695502 plus chemotherapy to Avastin plus chemotherapy in non-small cell lung cancer has completed with results …
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer [NA]
Clinical trial completion for SBRT in metastatic non-small cell lung cancer with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC [NA]
Clinical trial update reporting dose escalation of bevacizumab with ambulatory blood pressure monitoring in patients with advanced non-squam…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Adjuvant Pazopanib in Stage I NSCLC [Phase 2, Phase 3]
Clinical trial update on adjuvant pazopanib in stage I non-small cell lung cancer (Phase 2/Phase 3) finished recruitment; status completed.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. [Phase 1]
Phase I trial update for investigational compound LTT462 in adults with advanced cancers; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer [Phase 3]
A Phase 3 randomized trial comparing pemetrexed plus cisplatin versus gemcitabine plus cisplatin in locally advanced or metastatic non-small…
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Real World Data on Gi(l)Otrif® Dose Adjustment
Real-world data study on dose adjustment for Gi(l)Otrif® in non-small cell lung carcinoma completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC [Phase 2]
Phase 2 study evaluating nivolumab with or without docetaxel in patients previously treated with advanced or metastatic non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial evaluating azacitidine and entinostat in recurrent advanced non-small cell lung cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC [Phase 3]
Phase 3 clinical trial update evaluating consolidation sintilimab after concurrent chemoradiation in patients with unresectable stage III no…
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance
A terminated clinical trial evaluated whether nurse-led telephone support affects treatment compliance in non-small cell lung carcinoma pati…